- Report
- January 2026
- 185 Pages
Global
From €3127EUR$3,545USD£2,711GBP
€3474EUR$3,939USD£3,012GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,133GBP
- Report
- September 2025
- 142 Pages
Global
From €3500EUR$4,251USD£3,141GBP
- Report
- October 2025
- 456 Pages
Global
From €4366EUR$4,950USD£3,786GBP
- Report
- January 2026
- 187 Pages
Global
From €3127EUR$3,545USD£2,711GBP
€3474EUR$3,939USD£3,012GBP
- Report
- August 2025
- 193 Pages
Global
From €3127EUR$3,545USD£2,711GBP
€3474EUR$3,939USD£3,012GBP
- Report
- August 2025
- 180 Pages
Global
From €3127EUR$3,545USD£2,711GBP
€3474EUR$3,939USD£3,012GBP
- Report
- August 2025
- 192 Pages
Global
From €3127EUR$3,545USD£2,711GBP
€3474EUR$3,939USD£3,012GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,434GBP
- Report
- August 2025
- 190 Pages
Global
From €3127EUR$3,545USD£2,711GBP
€3474EUR$3,939USD£3,012GBP
- Report
- May 2026
- 362 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 478 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Report
- May 2026
- 381 Pages
Global
From €5160EUR$5,850USD£4,474GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,133GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,785GBP
- Report
- December 2025
- 150 Pages
Global
From €4278EUR$4,850USD£3,709GBP
- Report
- August 2025
- 150 Pages
Global
From €4278EUR$4,850USD£3,709GBP
- Report
- February 2026
- 160 Pages
Global
From €2928EUR$3,320USD£2,539GBP
€3660EUR$4,150USD£3,174GBP
- Report
- June 2025
- 89 Pages
North America
From €3043EUR$3,450USD£2,638GBP

The Type 2 Diabetes Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat Type 2 Diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin properly. Type 2 Diabetes Drugs are used to help control blood sugar levels, reduce the risk of complications, and improve overall health. These drugs can be taken orally, injected, or inhaled. Common Type 2 Diabetes Drugs include Metformin, Sulfonylureas, Thiazolidinediones, Meglitinides, DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors.
Some companies in the Type 2 Diabetes Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, Boehringer Ingelheim, and Takeda. Show Less Read more